Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis

INTRODUCTION: BMS-663068 is a prodrug of BMS-626529, an attachment inhibitor that binds directly to HIV-1 gp120, preventing initial viral attachment and entry into the host CD4+ T-cell. AI438011 is an ongoing, Phase IIb, randomized, active-controlled trial investigating the safety, efficacy and dose...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Int AIDS Soc
Главные авторы: Lalezari, Jacob, Latiff, Gulam H, Brinson, Cynthia, Echevarria, Juan, Treviño-Pérez, Sandra, Bogner, Johannes R, Stock, David, Joshi, Samit R, Hanna, George J, Lataillade, Max
Формат: Artigo
Язык:Inglês
Опубликовано: International AIDS Society 2014
Предметы:
Oral Presentation – Abstract O432B
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224850/
https://ncbi.nlm.nih.gov/pubmed/25394039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19530
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы